×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CPRX – catalyst pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CPRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/12
04:13 pm
cprx
Catalyst Pharmaceuticals (NASDAQ:CPRX) was upgraded by analysts at Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
Medium
Report
Catalyst Pharmaceuticals (NASDAQ:CPRX) was upgraded by analysts at Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
12/10
10:39 am
cprx
Analysts See Big Upside in Catalyst Pharmaceuticals, Inc. (CPRX) [Yahoo! Finance]
Low
Report
Analysts See Big Upside in Catalyst Pharmaceuticals, Inc. (CPRX) [Yahoo! Finance]
12/4
05:36 am
cprx
Is There Still Value in Catalyst Pharmaceuticals After Its 540% Five Year Surge? [Yahoo! Finance]
Low
Report
Is There Still Value in Catalyst Pharmaceuticals After Its 540% Five Year Surge? [Yahoo! Finance]
12/3
05:38 pm
cprx
Catalyst: Firdapse Cliff Deferred, But Capital Allocation Still An Issue (Upgrade) [Seeking Alpha]
Low
Report
Catalyst: Firdapse Cliff Deferred, But Capital Allocation Still An Issue (Upgrade) [Seeking Alpha]
11/28
01:37 am
cprx
A Fresh Look at Catalyst Pharmaceuticals (CPRX) Valuation Following Recent Share Price Momentum [Yahoo! Finance]
Low
Report
A Fresh Look at Catalyst Pharmaceuticals (CPRX) Valuation Following Recent Share Price Momentum [Yahoo! Finance]
11/24
08:03 am
cprx
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
Low
Report
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
11/19
08:03 am
cprx
Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™
Low
Report
Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™
11/18
08:03 am
cprx
Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
Low
Report
Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
Date
Time
Symbol
Company Name
Action
%Chg
11/5/2025
04:06 pm
CPRX
catalyst pharmaceuticals, inc.
BEAT
Report
-6.8%
catalyst pharmaceuticals, inc.
8/6/2025
04:13 pm
CPRX
catalyst pharmaceuticals, inc.
BEAT
Report
-9.8%
catalyst pharmaceuticals, inc.
5/7/2025
04:14 pm
CPRX
catalyst pharmaceuticals, inc.
BEAT
Report
-6.2%
catalyst pharmaceuticals, inc.
2/26/2025
04:13 pm
CPRX
catalyst pharmaceuticals, inc.
BEAT
Report
-0.7%
catalyst pharmaceuticals, inc.
Date
Time
Symbol
Headline
Impact
12/12
04:25 pm
cprx
Form 144 CATALYST PHARMACEUTICALS Filed by: Harper Molly
Low
Report
Form 144 CATALYST PHARMACEUTICALS Filed by: Harper Molly
12/10
05:01 pm
cprx
Form 4 CATALYST PHARMACEUTICALS For: Dec 08 Filed by: Thompson Tamar
Low
Report
Form 4 CATALYST PHARMACEUTICALS For: Dec 08 Filed by: Thompson Tamar
12/10
05:01 pm
cprx
Form 4 CATALYST PHARMACEUTICALS For: Dec 08 Filed by: Tierney David S
Low
Report
Form 4 CATALYST PHARMACEUTICALS For: Dec 08 Filed by: Tierney David S
12/10
05:01 pm
cprx
Form 4 CATALYST PHARMACEUTICALS For: Dec 08 Filed by: Elsbernd Brian
Low
Report
Form 4 CATALYST PHARMACEUTICALS For: Dec 08 Filed by: Elsbernd Brian
12/10
05:01 pm
cprx
Form 4 CATALYST PHARMACEUTICALS For: Dec 08 Filed by: MCENANY PATRICK J
Low
Report
Form 4 CATALYST PHARMACEUTICALS For: Dec 08 Filed by: MCENANY PATRICK J
12/10
05:01 pm
cprx
Form 4 CATALYST PHARMACEUTICALS For: Dec 08 Filed by: Del Carmen Jeffrey
Low
Report
Form 4 CATALYST PHARMACEUTICALS For: Dec 08 Filed by: Del Carmen Jeffrey
12/10
05:01 pm
cprx
Form 4 CATALYST PHARMACEUTICALS For: Dec 08 Filed by: Sundaram Preethi
Low
Report
Form 4 CATALYST PHARMACEUTICALS For: Dec 08 Filed by: Sundaram Preethi
12/10
05:01 pm
cprx
Form 4 CATALYST PHARMACEUTICALS For: Dec 08 Filed by: DENKHAUS DONALD A
Low
Report
Form 4 CATALYST PHARMACEUTICALS For: Dec 08 Filed by: DENKHAUS DONALD A
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
5/9
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating.
15.9%
5/14 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was given a new $9.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. 12.7%
4/8 Catalyst Pharmaceuticals Provides Update on Impact of COVID-19 Pandemic on its Business Activities 11.5%
1/6 Catalyst Pharmaceuticals Pre-Announces Estimated Firdapse® Revenues and Provides Updates on Advancement of Clinical Development Programs 11.1%
3/10 Catalyst Pharmaceuticals to Hold Fourth Quarter and Year-End Financial Results and Corporate Update Conference Call and Webcast on Tuesday, March 17th, 2020 9.8%
2/5 Form 8-K CATALYST PHARMACEUTICALS For: Feb 04 9.5%
3/16 Q4/2019 12/31/2019 EPS 0.070 ZacksConsensus 0.090 ActVsEst (0.020) - Miss 8.6%
6/12 Catalyst Pharmaceuticals Files Federal Lawsuit Against U.S. Food and Drug Administration 7.9%
11/13 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) had its price target lowered by analysts at Piper Jaffray Companies from $8.00 to $7.00. 5.6%
9/24 Form 8-K CATALYST PHARMACEUTICALS For: Sep 23 5.5%
5/14 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was given a new $9.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. 12.7%
4/8 Catalyst Pharmaceuticals Provides Update on Impact of COVID-19 Pandemic on its Business Activities 11.5%
1/6 Catalyst Pharmaceuticals Pre-Announces Estimated Firdapse® Revenues and Provides Updates on Advancement of Clinical Development Programs 11.1%
3/10 Catalyst Pharmaceuticals to Hold Fourth Quarter and Year-End Financial Results and Corporate Update Conference Call and Webcast on Tuesday, March 17th, 2020 9.8%
2/5 Form 8-K CATALYST PHARMACEUTICALS For: Feb 04 9.5%
3/16 Q4/2019 12/31/2019 EPS 0.070 ZacksConsensus 0.090 ActVsEst (0.020) - Miss 8.6%
6/12 Catalyst Pharmaceuticals Files Federal Lawsuit Against U.S. Food and Drug Administration 7.9%
11/13 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) had its price target lowered by analysts at Piper Jaffray Companies from $8.00 to $7.00. 5.6%
9/24 Form 8-K CATALYST PHARMACEUTICALS For: Sep 23 5.5%
TOP News Decliners
3/15
Catalyst Pharmaceuticals Q4 2019 Earnings Preview [Seeking Alpha]
-23.2%
9/11 Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock -14.9%
10/30 Catalyst Pharmaceuticals Announces Top-Line Results of CMS-001, a Phase 3 Trial of Firdapse® (Amifampridine Phosphate) in Patients with Congenital Myasthenic Syndromes (CMS) -14.5%
4/14 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -12.1%
5/13 Form 8-K CATALYST PHARMACEUTICALS For: May 13 -11.7%
8/7 Q2/2019 6/30/2019 EPS 0.100 ZacksConsensus 0.030 ActVsEst 0.070 - Beat -10.7%
2/27 Catalyst Pharmaceuticals Announces Support of Rare Disease Day 2020 -10.3%
12/20 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -8.9%
9/13 Form 8-K CATALYST PHARMACEUTICALS For: Sep 13 -8.0%
11/12 Form 10-Q CATALYST PHARMACEUTICALS For: Sep 30 -7.3%
9/11 Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock -14.9%
10/30 Catalyst Pharmaceuticals Announces Top-Line Results of CMS-001, a Phase 3 Trial of Firdapse® (Amifampridine Phosphate) in Patients with Congenital Myasthenic Syndromes (CMS) -14.5%
4/14 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -12.1%
5/13 Form 8-K CATALYST PHARMACEUTICALS For: May 13 -11.7%
8/7 Q2/2019 6/30/2019 EPS 0.100 ZacksConsensus 0.030 ActVsEst 0.070 - Beat -10.7%
2/27 Catalyst Pharmaceuticals Announces Support of Rare Disease Day 2020 -10.3%
12/20 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -8.9%
9/13 Form 8-K CATALYST PHARMACEUTICALS For: Sep 13 -8.0%
11/12 Form 10-Q CATALYST PHARMACEUTICALS For: Sep 30 -7.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: